5MW3
Crystal structure of Dot1L in complex with inhibitor CPD1 [N6-(2,6-dichlorophenyl)-N6-(pent-2-yn-1-yl)quinoline-4,6-diamine] and inhibitor CPD2 [(R)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-3-amine]
Summary for 5MW3
Entry DOI | 10.2210/pdb5mw3/pdb |
Descriptor | Histone-lysine N-methyltransferase, H3 lysine-79 specific, N~6~-(2,6-dichlorophenyl)-N~6~-(pent-2-yn-1-yl)quinoline-4,6-diamine, (3R)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-3-amine, ... (5 entities in total) |
Functional Keywords | inhibitor, complex, methyltransferase, transferase |
Biological source | Homo sapiens (Human) |
Cellular location | Nucleus : Q8TEK3 |
Total number of polymer chains | 2 |
Total formula weight | 78238.36 |
Authors | Be, C.,Koch, E.,Gaul, C.,Stauffer, F.,Moebitz, H.,Scheufler, C. (deposition date: 2017-01-18, release date: 2017-03-22, Last modification date: 2024-01-17) |
Primary citation | Mobitz, H.,Machauer, R.,Holzer, P.,Vaupel, A.,Stauffer, F.,Ragot, C.,Caravatti, G.,Scheufler, C.,Fernandez, C.,Hommel, U.,Tiedt, R.,Beyer, K.S.,Chen, C.,Zhu, H.,Gaul, C. Discovery of Potent, Selective, and Structurally Novel Dot1L Inhibitors by a Fragment Linking Approach. ACS Med Chem Lett, 8:338-343, 2017 Cited by PubMed: 28337327DOI: 10.1021/acsmedchemlett.6b00519 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.09 Å) |
Structure validation
Download full validation report![Download](/newweb/media/icons/dl.png)
![Download](/newweb/media/icons/dl.png)